![Maninder Hora](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maninder Hora
Technik-/Wissenschafts-/F&E-Leiter bei
VIR BIOTECHNOLOGY, INC.
Profil
Dr. Maninder Hora is a Chief Technical Operations Officer & Executive VP at Vir Biotechnology, Inc. Dr. Hora was previously employed as a Chief Technical Operations Officer by Amunix Pharmaceuticals, Inc., a Chief Technical Operations Officer by Nektar Therapeutics, a Vice President-Product Operations & Quality by Abbott Biotherapeutics Corp., a Vice President-Product Operations by PDL BioPharma, Inc., a Vice President-Process & Product Development by Chiron Corp., a Vice President by GSK Plc, a Vice President-Process & Product Development by Novartis Pharmaceuticals Corp., and a Vice President by Wyeth Pharmaceuticals LLC.
He received his undergraduate degree from Rani Durgavati University and a doctorate degree from Indian Institute of Technology New Delhi.
Aktive Positionen von Maninder Hora
| Unternehmen | Position | Beginn |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Technik-/Wissenschafts-/F&E-Leiter | 27.02.2025 |
Ehemalige bekannte Positionen von Maninder Hora
| Unternehmen | Position | Ende |
|---|---|---|
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops transformative T cell engagers (TCEs) and cytokine therapies for patients with cancer | Geschäftsführer | 01.11.2023 |
| NEKTAR THERAPEUTICS | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2019 |
Abbott Biotherapeutics Corp.
 Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for the treatment of oncology and immunologic diseases | Corporate Officer/Principal | 01.07.2010 |
| PDL BIOPHARMA, INC. | Corporate Officer/Principal | 01.12.2008 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Corporate Officer/Principal | 01.05.2006 |
Ausbildung von Maninder Hora
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
79
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Nektar Therapeutics
 Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets infant pharmaceutical products | Health Technology |
Abbott Biotherapeutics Corp.
Abbott Biotherapeutics Corp. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for the treatment of oncology and immunologic diseases | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Indian Institute of Technology New Delhi
 Indian Institute of Technology New Delhi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
Rani Durgavati University
 Rani Durgavati University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops transformative T cell engagers (TCEs) and cytokine therapies for patients with cancer | Health Technology |
Wählen Sie MarketScreener 
